Evidence map›Paper›PMID 16939660›Full record

ArticleCardiovascular diabetology2006

Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes.

Sabine Abke, Markus Neumeier, Johanna Weigert, Gabriele Wehrwein, Elke Eggenhofer, Andreas Schäffler, Kevin Maier, Charalampos Aslanidis, Jürgen Schölmerich, Christa Buechler

Open access · goldAbstract read
In one paragraph

Article in Cardiovascular diabetology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Chemokines in Type 1 Diabetes Mellitus.Frontiers in immunology · 2021
    Article
  5. Article
  6. Adipokines in Liver Cirrhosis.International journal of molecular sciences · 2017
    Review
  7. Article
  8. Article
  9. Review
  10. Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2015
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Dysregulation of maternal serum adiponectin in preterm labor.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2009
    Article
  17. Maternal serum adiponectin multimers in preeclampsia.Journal of perinatal medicine · 2009
    Article
  18. Article
  19. Adiponectin multimers in maternal plasma.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2008
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sabine AbkeDepartment of Internal Medicine I, University of Regensburg, D-93042 Regensburg, Germany. abs507310@gw.ngate.uni-regensburg.de
Markus Neumeier
Johanna Weigert
Gabriele Wehrwein
Elke Eggenhofer
Andreas Schäffler
Kevin Maier
Charalampos Aslanidis
Jürgen Schölmerich
Christa Buechler
University of Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSystemic adiponectin is reduced in patients with cardiovascular disease (CVD) and low adiponectin may contribute to the pathogenesis of atherosclerosis. However, circulating adiponectin is elevated in type 1 diabetes (T1D) patients, who have also a higher incidence to develop CVD. Because monocytes play an important role in atherosclerosis, we analysed the influence of adiponectin on cytokine and chemokine release in monocytes from T1D patients and controls.

methodsSystemic adiponectin was determined in the plasma and the high-molecular weight (HMW) form of adiponectin was analysed by immunoblot. Monocytes were isolated from T1D patients and controls and the adiponectin-stimulated release of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) was analysed.

resultsSystemic adiponectin was higher in T1D patients. Immunoblot analysis of the plasma indicate abundance of HMW adiponectin in T1D patients and controls. IL-6, CCL2 and CXCL8 secretion in response to adiponectin were found induced in monocytes from controls whereas only IL-6 was upregulated in T1D cells. The induction of IL-6 by adiponectin was abrogated by an inhibitor of the NFkappaB pathway.

conclusionThese data indicate that adiponectin-mediated induction of IL-6, CCL2 and CXCL8 is disturbed in monocytes from T1D patients and therefore elevated systemic adiponectin in T1D patients may be less protective when compared to controls.

Indexed as

AdiponectinAdolescentAdultBody Mass IndexChemokine CCL2Diabetes Mellitus, Type 1HumansInterleukin-6Interleukin-8Middle AgedMonocytesRecombinant ProteinsReference ValuesAdiponectinCCL2 protein, humanChemokine CCL2Interleukin-6Interleukin-8Recombinant Proteins

Identifiers

PMID16939660
PMCPMC1563998
OpenAlexW1491447523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.